Caxton Associates LP Baxter International Inc Transaction History

Caxton Associates LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $1.26 Million - $1.46 Million	25,265 New	25,265 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$63.83 - $80.0 $245,107 - $307,200	3,840 New	3,840 $247,000
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $239,781 - $269,068	-3,265 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$64.48 - $81.31 $210,527 - $265,477	3,265 New	3,265 $265,000
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $410,240 - $519,392	-6,676 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $12,444 - $13,684	-176 Reduced 2.57%	6,676 $515,000
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $1.01 Million - $1.2 Million	-15,957 Reduced 69.96%	6,852 $506,000
Q1 2018 May 15, 2018	SELL	$62.56 - $72.26 $5,255 - $6,069	-84 Reduced 0.37%	22,809 $1.48 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $749,259 - $805,347	12,193 Added 113.95%	22,893 $1.48 Million
Q3 2017 Nov 14, 2017	SELL	$59.5 - $64.61 $5,950 - $6,461	-100 Reduced 0.93%	10,700 $671,000
Q2 2017 Aug 29, 2017	BUY	N/A	10,800	10,800 $654,000

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

Stay updated on Caxton Associates LP with notifications on news.